In Section A, participants will acquire unique doses and schedules of oral ABBV-744 tablet to determine safe dosing routine. Added individuals will probably be enrolled at the discovered monotherapy dosign routine. In Phase B, individuals will acquire oral ruxolitinib and ABBV-744 might be presented